Acronym:
RESCIND
ACTRN/NCT /ethics:
Scientific title:
Summary of trial and patient characteristics
| Cancer Type | All cancers | ||
|---|---|---|---|
| Trial Type | Early detection, diagnosis, prognosis | ||
| Phase | Tumour Stream | All cancers | |
| Age Range | All ages | Cancer Stage | |
| Sex | Both | Anticipated Start Date | |
| Molecular Target | Anticipated End Date | ||
| Cancer Type | All cancers |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | |
| Age Range | All ages |
| Sex | Both |
| Molecular Target | |
| Tumour Stream | All cancers |
| Cancer Stage | |
| Anticipated Start Date | |
| Anticipated End Date |
Trial Summary
Resistant Starch for Chemotherapy Induced diarrhoea: a feasibility study
Lay Summary
Sponsor / Cooperative group
Participating Hospitals
| Hospital | Clinical Trial Coordinator | Phone | Principal Investigator | Recruitment Status | |
|---|---|---|---|---|---|
| Flinders Medical Centre | Alex Scott-Hoy | alex.scott-hoy@sa.gov.au | 08 8204 4830 | Amitesh Roy | Recruitment on Hold |